ONCO3
SCORE 1.9Goldman Sachs reduces derivatives exposure to 0.7% of Oncoclínicas (ONCO3)
GLQ Broad Street, a Goldman Sachs–linked vehicle, reduces its economic exposure via derivatives to 0.70% of Oncoclínicas (ONCO3), while Josephina I holds 4.845% in shares.
Read storyOncoclínicas (ONCO3) announces sale of joint venture in Saudi Arabia
Oncoclínicas (ONCO3) approves sale of 100% of its stake in the joint venture Specialized Medical Treatment Company for about US$ 6.55 million.
Read storyJosephina III cuts stake to 9% in Oncoclínicas (ONCO3)
Josephina III cuts its stake to 9.911% in Oncoclínicas (ONCO3), holding 112,498,778 shares, while Centaurus TRS reduces its exposure via swap to 0.70% of capital.
Read storyOncoclínicas (ONCO3) registers R$ 500 million debenture offering
Oncoclínicas (ONCO3) reports on 07/15/2026 that it received a non-binding offer from IG4 for R$ 500 million in convertible debentures, with no decision on acceptance.
Read storyOncoclínicas (ONCO3) files for out-of-court reorganization
Oncoclínicas (ONCO3) filed on 07/13/2026 for out-of-court reorganization to restructure around R$ 5.1 billion in unsecured financial debt.
Read story